In summary, we have shown that JC-5411 can act as a Nrf2 activator which in turn inhibits the progression of atherosclerosis in ApoE−/− mice, and demonstrate that this inhibition is achieved through multiple mechanisms including the attenuation of inflammation, regulation of dysregulated lipid metabolism and increase in antioxidant activity. This evidence concerns the gene NFE2L2 and atherosclerosis.